China-based drug developer Adagene raises $69m led by General Atlantic

China-based drug developer Adagene raises $69m led by General Atlantic

Adagene is a clinical stage oncology-based biotech company

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter